Arcadia Q3 net income $856k vs loss $1.6M YoY; Zola YTD revenue up 26%

Arcadia Biosciences, Inc.

2025-Q3 EPS reported -$0.73 revenue$3,957,000

Q3 total revenue $1.30M, down 15% YoY; loss from operations $1.15M.
Net income attributable to common $856k ($0.63 diluted EPS) vs loss $1.61M ($1.18 loss) in Q3 2024.
Zola coconut water YTD revenue up 26% YoY; gross margin >30% for 11th straight quarter.
Cash balance $1.12M at Sept 30, 2025; pending Roosevelt Resources combination delayed by federal shutdown.
Recognized $4.7M credit loss on Above Food note; holds 2.7M ABVE shares valued at $3.07M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.